Proteasome Inhibitors

Proteasome inhibitors are drugs designed to block, or inhibit, the ability of cancer cells to use certain proteins to carry out the cell cycle. When they are unable to complete this process, the result is the death of the cell.

Currently, just a few proteasome inhibitors are available on the market, but they are in wide use. They are:

Lymphoma Treatment Center

Insurance Accepted.
Innovative Lymphoma Treatments.
Call 415-343-6162 Today

Velcade
Velcade is a targeted treatment, meaning it does not kill cells indiscriminately but rather has a molecular target it seeks out. Click here for more information on Velcade and how it works. Velcade is FDA approved to treat multiple myeloma (a type of bone marrow cancer) as well as patients with mantle cell lymphoma who have failed first-line therapy.

Thalidomide and Revlimid.
These two drugs are very similar in that they work as immune system modulators. They also possess what's known as an anti-angiogenetic effect: in short, tumors create blood vessels that they use to nourish their own growth. This network-building is called angiogenesis; thus an anti-angiogenesis blocks the formation of those blood vessels. Furthermore, these drugs are believed to inhibit the proliferation of blood-borne tumor cells while at the same time boosting the number of T-cell and NK cells in the body to help bolster the immune system

In cancer treatment, thalidomide in combination with dexamethasone has been approved as a first-line treatment in some patients with a bone marrow cancer known as multiple myeloma. Thalidomide may be familiar to some for the severe birth defects the drug caused back in the late 1950s and early 1960s. The drug is still very dangerous to take for pregnant women—and plenty of safeguards are in place to be sure that pregnant women are not given the drug. However, it has been found to be safe and effective in certain other settings.

Revlimid (lenalidomide) is also an anti-angiogenetic and is also approved to treat multiple myeloma. Like thalidomide, Revlimid comes with plenty of risks, especially to a child in the womb. Furthermore, Revlimid is among the drugs given black box warning in the past few years by the FDA because of troubling reports of people on the drug developing secondary cancers including non-Hodgkin's lymphomas. The FDA issued a notice in April of 2011 which informed the public that the agency was:

"aware of results from clinical trials conducted inside and outside the United States that found that patients treated with Revlimid (lenalidomide) may be at an increased risk of developing new types of cancer compared to patients who did not take the drug. FDA is currently reviewing all available information on this potential risk and will communicate any new recommendations once it has completed its review."

Sources

MedlinePLus, thalidomide
National Cancer Institute, thalidomide
National Cancer Institute, Revlimid
FDA Ongoing Safety Review, Revlimid
Lymphoma Information Network, Velcade
BC Cancer Agency, Revlimid
BC Cancer Agency, Thalidomide

Lymphoma Treatment Center

Insurance Accepted.
Innovative Lymphoma Treatments.
Call 415-343-6162 Today

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...